Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH

ClinicalTrials.gov ID: NCT05591079

Public ClinicalTrials.gov record NCT05591079. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 6:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of CS0159 in the Treatment of Patients With Nonalcoholic Steatohepatitis (NASH)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A randomized, double-blind study to assess the safety, tolerability, PK and efficacy of CS0159 in subjects with Non-Alcoholic Steatohepatitis (NASH)

Study identification

NCT ID
NCT05591079
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
99 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 10, 2023 (Actual)
Primary completion
Nov 9, 2023 (Actual)
Completion
Nov 9, 2023 (Actual)
Last update posted
Nov 21, 2023

2023

United States locations

U.S. sites
17
U.S. states
7
U.S. cities
16
Facility City State ZIP Site status
National Research Institute - Gardena Gardena California 90247-3586 —
Velocity Clinical Research, Huntington Park Huntington Park California 90255-2959 —
Velocity Clinical Research - Panorama City Panorama City California 91402-3022 —
Velocity Clinical Research - Santa Ana Santa Ana California 92704 —
Ocala GI Research Lady Lake Florida 32159 —
Florida Research Institute Lakewood Florida 34211-4930 —
San Marcus Research Clinic, Inc - Miami Miami Florida 33014-5602 —
Floridian Clinical Research, LLC - Miami Lakes Miami Lakes Florida 33016-1518 —
Gastroenterology Associates of Ocala Ocala Florida 34471 —
Oracle Clinical Research College Park Georgia 30349 —
Metropolitan Gastroenterology Associates - Westbank Office and Endoscopy Marrero Louisiana 70072 —
Raja M. Din MD, PLLC - Gastroenterology & Hepatology Greenbelt Maryland 20770-6702 —
Lucas Research Morehead City North Carolina 28557 —
Texas Liver Institute (TLI) - Austin Austin Texas 78757-7571 —
Pioneer Research Solutions Inc - Houston - Stancliff Rd Houston Texas 77099-4307 —
The Texas Liver Institute, Inc. San Antonio Texas 78215 —
Clinical Trials of Texas, LLC San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05591079, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 21, 2023 · Synced Nov 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05591079 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →